Reversing stage III oral adenocarcinoma in a dog treated with anti-canine PD-1 therapeutic antibody: a case report

Monoclonal antibody targeting programmed cell death-1 (PD-1) is one of the most promising treatment therapies for human cancers. Canine PD-1 antibodies used in clinical trials have also shown efficacy in treating canine cancers. An 11-year-old male intact border collie presented to us for evaluation...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Shuo, Xie, Jingshu, Wang, Shuaiyu, Tang, Na, Feng, Junli, Su, Youhong, Li, Gebin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Veterinary Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219605/
https://www.ncbi.nlm.nih.gov/pubmed/37252387
http://dx.doi.org/10.3389/fvets.2023.1144869

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219605/
https://www.ncbi.nlm.nih.gov/pubmed/37252387
http://dx.doi.org/10.3389/fvets.2023.1144869

Ejemplares similares